시장보고서
상품코드
1462961

시스타틴 C 측정 시장, 점유율, 시장 규모, 동향, 산업 분석 보고서 : 제품별, 방법별, 용도별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)

Cystatin C Assay Market Share, Size, Trends, Industry Analysis Report, By Product (Kits, Reagents, and Analyzers); By Sample Type; By Method; By Application, By End-user, By Region; Segment Forecast, 2024- 2032

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 시스타틴 C 측정 시장 규모는 2032년까지 5억 9,029만 9,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

만성 신장 질환(CKD)의 유병률 증가와 노인 인구 증가는 시스타틴 C 측정 시장의 성장을 가속하는 주요 요인 중 일부입니다. 신장 기능 저하는 빈혈, 면역력 저하, 식욕 부진, 칼슘 농도 저하 등 다양한 건강 문제를 유발할 수 있습니다. 이러한 건강 문제에 대한 우려가 높아지면서 시스타틴 C 측정 방법에 대한 수요가 증가하고 있습니다. 또한, 당뇨병, 고혈압, 심장병 환자에서 CKD의 위험이 높고, 이들 질환의 유병률과 사망률이 증가함에 따라 향후 몇 년동안 시장 성장에 긍정적인 영향을 미칠 것으로 보입니다. 예를 들어, 미국 질병예방통제센터(CDC)에 따르면 2021년 미국에서 고혈압은 69만 1,095명의 사망을 유발하는 주요 원인으로 꼽힙니다.

시스타틴 C 측정은 크레아티닌 검사에 비해 많은 장점이 있기 때문에 큰 인기를 끌고 있습니다. 예를 들어, 시스타틴 C는 개인의 체격이나 식단의 영향을받지 않기 때문에 신장 기능의 신뢰할 수있는 지표가 될 수 있습니다. 또한 신장 관련 질환에 대한 지출을 늘리려는 정부의 강력한 강조와 신장 질환 환자 인구 증가는 시스타틴 C 측정에 대한 수요를 촉진하고 시장 성장에 박차를 가할 것으로 예상됩니다.

신장병 조기 검진의 이점에 대한 인식이 높아지면 시스타틴 C 측정 시장의 성장에 도움이 될 것입니다. 또한, 극심한 비만, 간경변, 사지 절단, 근육량 감소가 있는 환자에서 시스타틴 C 측정의 정확한 결과와 높은 신뢰성은 크레아티닌 검사에 대한 선호도를 높일 것으로 보입니다. 또한 사구체신염을 앓고 있는 환자들은 말기 신장 질환에 걸릴 확률이 높을 것으로 예상되어 시스타틴 C 측정에 대한 수요를 창출할 것으로 예상됩니다. 예를 들어, 미국 신장 데이터 시스템(USRDS)에 따르면 2020년 사구체 신염은 말기 신장 질환의 주요 원인 중 15.0%의 점유율을 차지할 것으로 예상됩니다.

시스타틴 C 측정법 시장 보고서 하이라이트

시스타틴 C 측정을 수행하기위한 종합적인 솔루션에 대한 요구를 충족시키기 위해 키트 분야가 시장을 장악했습니다.

혈액 부문은 의료 시설과 임상 실험실에서 혈액 샘플에 대한 선호도가 높기 때문에 시장에서 가장 큰 점유율을 차지하고 있습니다.

효소 결합 면역 흡착 분석법(ELISA) 분야가 가장 큰 시장 점유율을 차지했는데, 이는 ELISA 검사 과정이 간단하고 쉽게 구할 수 있는 등의 요인에 기인합니다.

진단약 부문은 만성콩팥병(CKD) 조기 검진 검사에 대한 수요 증가로 인해 시장을 장악했습니다.

북미는 만성 신장 질환의 유병률이 높고, 의료 시스템이 정교한 만큼 가장 큰 시장 점유율을 차지하고 있습니다.

시장 진출기업으로는 Roche Diagnostics Limited, Siemens Healthineers AG, Abbott, Beckman Coulter, Inc. 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 시스타틴 C 측정 시장 인사이트

  • 시스타틴 C 측정 - 업계 현황
  • 시스타틴 C 측정 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • PESTLE 분석
  • 시스타틴 C 측정 업계 동향
  • COVID-19의 영향 분석

제5장 제품별 세계 시장

  • 주요 조사 결과
  • 서론
  • 키트
  • 시약
  • 분석 장비

제6장 방법별 세계 시장

  • 주요 조사 결과
  • 서론
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • Particle-Enhanced Nephelometric Immunoassay (PENIA)
  • Chemiluminescent Immunoassay (CLIA)
  • Immunofluorescence Assay
  • 기타

제7장 샘플 유형별 세계 시장

  • 주요 조사 결과
  • 서론
  • 혈액
  • 소변

제8장 용도별 세계 시장

  • 주요 조사 결과
  • 서론
  • 진단
  • 연구

제9장 최종사용자별 세계 시장

  • 주요 조사 결과
  • 서론
  • 병원
  • 임상 실험실
  • 제약 기업 및 바이오테크놀러지 기업
  • 기타

제10장 지역별 세계 시장

  • 주요 조사 결과
  • 서론
    • 시스타틴 C 측정 시장 평가, 지역별, 2019-2032년
  • 시스타틴 C 측정 시장 - 북미
    • 북미 : 시스타틴 C 측정 시장, 제품별, 2019-2032년
    • 북미 : 시스타틴 C 측정 시장, 용도별, 2019-2032년
    • 북미 : 시스타틴 C 측정 시장, 방법별, 2019-2032년
    • 북미 : 시스타틴 C 측정 시장, 샘플 유형별, 2019-2032년
    • 북미 : 시스타틴 C 측정 시장, 최종사용자별, 2019-2032년
    • 시스타틴 C 측정 시장 - 미국
    • 시스타틴 C 측정 시장 - 캐나다
  • 시스타틴 C 측정 시장 - 유럽
    • 유럽 : 시스타틴 C 측정 시장, 제품별, 2019-2032년
    • 유럽 : 시스타틴 C 측정 시장, 용도별, 2019-2032년
    • 유럽 : 시스타틴 C 측정 시장, 방법별, 2019-2032년
    • 유럽 : 시스타틴 C 측정 시장, 샘플 유형별, 2019-2032년
    • 유럽 : 시스타틴 C 측정 시장, 최종사용자별, 2019-2032년
    • 시스타틴 C 측정 시장 - 영국
    • 시스타틴 C 측정 시장 - 프랑스
    • 시스타틴 C 측정 시장 - 독일
    • 시스타틴 C 측정 시장 - 이탈리아
    • 시스타틴 C 측정 시장 - 스페인
    • 시스타틴 C 측정 시장 - 네덜란드
    • 시스타틴 C 측정 시장 - 러시아
  • 시스타틴 C 측정 시장 - 아시아태평양
    • 아시아태평양 : 시스타틴 C 측정 시장, 제품별, 2019-2032년
    • 아시아태평양 : 시스타틴 C 측정 시장, 용도별, 2019-2032년
    • 아시아태평양 : 시스타틴 C 측정 시장, 방법별, 2019-2032년
    • 아시아태평양 : 시스타틴 C 측정 시장, 샘플 유형별, 2019-2032년
    • 아시아태평양 : 시스타틴 C 측정 시장, 최종사용자별, 2019-2032년
    • 시스타틴 C 측정 시장 - 중국
    • 시스타틴 C 측정 시장 - 인도
    • 시스타틴 C 측정 시장 - 일본
    • 시스타틴 C 측정 시장 - 말레이시아
    • 시스타틴 C 측정 시장 - 인도네시아
    • 시스타틴 C 측정 시장 - 한국
  • 시스타틴 C 측정 시장 - 중동 및 아프리카
    • 중동 및 아프리카 : 시스타틴 C 측정 시장, 제품별, 2019-2032년
    • 중동 및 아프리카 : 시스타틴 C 측정 시장, 용도별, 2019-2032년
    • 중동 및 아프리카 : 시스타틴 C 측정 시장, 방법별, 2019-2032년
    • 중동 및 아프리카 : 시스타틴 C 측정 시장, 샘플 유형별, 2019-2032년
    • 중동 및 아프리카 : 시스타틴 C 측정 시장, 최종사용자별, 2019-2032년
    • 시스타틴 C 측정 시장 - 사우디아라비아
    • 시스타틴 C 측정 시장 - UAE
    • 시스타틴 C 측정 시장 - 이스라엘
    • 시스타틴 C 측정 시장 - 남아프리카
  • 시스타틴 C 측정 시장 - 라틴아메리카
    • 라틴아메리카 : 시스타틴 C 측정 시장, 제품별, 2019-2032년
    • 라틴아메리카 : 시스타틴 C 측정 시장, 용도별, 2019-2032년
    • 라틴아메리카 : 시스타틴 C 측정 시장, 방법별, 2019-2032년
    • 라틴아메리카 : 시스타틴 C 측정 시장, 샘플 유형별, 2019-2032년
    • 라틴아메리카 : 시스타틴 C 측정 시장, 최종사용자별, 2019-2032년
    • 시스타틴 C 측정 시장 - 멕시코
    • 시스타틴 C 측정 시장 - 브라질
    • 시스타틴 C 측정 시장 - 아르헨티나

제11장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 파트너십/협업/계약/전시회

제12장 기업 개요

  • Abbott(U.S.)
  • Abcam plc(UK)
  • Agilent Technologies, Inc(U.S.)
  • Beckman Coulter, Inc.(U.S.)
  • bioMerieux, S.A(France)
  • Bio-Rad Laboratories, Inc(U.S.)
  • Bio-Techne(U.S.)
  • DiaSys Diagnostic Systems GmbH(Germany)
  • Randox Laboratories Ltd.(UK)
  • Roche Diagnostics Limited(Switzerland)
  • Siemens Healthcare Private Limited(India)
  • Sino Biological, Inc.(China)
  • Thermo Fisher Scientific Inc.(U.S.)
LSH 24.05.10

The global cystatin C assay market size is expected to reach USD 590.29 million by 2032, according to a new study by Polaris Market Research. The report "Cystatin C Assay Market Share, Size, Trends, Industry Analysis Report, By Product (Kits, Reagents, and Analyzers); By Sample Type; By Method; By Application; By End-user; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing prevalence of chronic kidney disease (CKD) and rising geriatric population are some of the major factors driving the growth of the cystatin C assay market. Lower kidney function can lead to various health problems, such as anemia, weak immunity, appetite loss, and low calcium levels. An increasing concern over these health problems is increasing the demand for cystatin C assays. Moreover, the high risk of CKD among patients with diabetes, hypertension, and heart diseases and the increasing prevalence and mortality rate of these diseases will positively impact the market growth in the coming years. For instance, according to the Centers for Disease Control & Prevention (CDC), in 2021, in the U.S., hypertension was a major cause of 691,095 deaths.

Cystatin C testing is gaining significant popularity due to its many advantages over creatinine testing. For instance, cystatin C is not affected by body mass or diet of an individual which makes it a reliable marker of kidney function. Moreover, the strong emphasis of the government to increase the expenditure on kidney-related diseases and the growing patient population suffering from kidney diseases are expected to propel the demand for cystatin C tests, thereby spurring market growth.

An increasing awareness related to the benefits of early screening of kidney disease will prove beneficial for the growth of the cystatin C assay market. Moreover, the accurate results and greater reliability of cystatin C tests in people with extreme obesity, liver cirrhosis, amputated limbs, and decreased muscle mass will increase its preference over the creatinine test. Furthermore, patients suffering from Glomerulonephritis are expected to increase the chances of end-stage kidney disease, thereby creating a demand for cystatin C assay. For instance, according to the U.S. Renal Data System (USRDS), in 2020, Glomerulonephritis held a 15.0% share among the major causes of end-stage kidney disease.

Cystatin C Assay Market Report Highlights

The kits segment dominated the market, as it serves the need for a comprehensive solution for carrying out the cystatin C assay.

The blood segment accounted for the largest share of the market, owing to the higher preference for blood samples by healthcare facilities and clinical laboratories.

The enzyme-linked immunosorbent assay (ELISA) segment held the largest market share, owing to factors such as simpler processes and easy availability of ELISA tests.

Diagnostics segment dominated the market, owing to an increasing demand for early screening tests for chronic kidney disease (CKD).

North America accounted for the largest market share, owing to the high burden of chronic kidney disease and sophisticated healthcare system.

The market players include Roche Diagnostics Limited, Siemens Healthineers AG, Abbott, Beckman Coulter, Inc., Thermo Fisher Scientific Inc., bioMerieux, S.A, and others.

Polaris Market Research has segmented the cystatin C assay market report based on product, sample type, method, application, end-user, and region:

Cystatin C Assay, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Kits
  • Reagents
  • Analyzers

Cystatin C Assay, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Blood
  • Urine

Cystatin C Assay, Method Outlook (Revenue - USD Million, 2019 - 2032)

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • Particle-Enhanced Nephelometric Immunoassay (PENIA)
  • Chemiluminescent Immunoassay (CLIA)
  • Immunofluorescence Assay
  • Others

Cystatin C Assay, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Diagnostics
  • Research

Cystatin C Assay, End-user Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Cystatin C Assay, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cystatin C Assay Market Insights

  • 4.1. Cystatin C Assay - Industry Snapshot
  • 4.2. Cystatin C Assay Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of chronic kidney diseases is expected to boost the cystatin C assay market growth
      • 4.2.1.2. Several advantages associated with the use of cystatin C test over creatinine test will drive the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Cystatin C assay's high costs are predicted to impede the market expansion
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cystatin C Assay Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Cystatin C Assay Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
  • 5.3. Kits
    • 5.3.1. Global Cystatin C Assay Market, by Kits, by Region, 2019-2032 (USD Million)
  • 5.4. Reagents
    • 5.4.1. Global Cystatin C Assay Market, by Reagents, by Region, 2019-2032 (USD Million)
  • 5.5. Analyzers
    • 5.5.1. Global Cystatin C Assay Market, by Analyzers, by Region, 2019-2032 (USD Million)

6. Global Cystatin C Assay Market, by Method

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
  • 6.3. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 6.3.1. Global Cystatin C Assay Market, by Enzyme-Linked Immunosorbent Assay (ELISA), by Region, 2019-2032 (USD Million)
  • 6.4. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
    • 6.4.1. Global Cystatin C Assay Market, by Particle-Enhanced Turbidimetric Immunoassay (PETIA), by Region, 2019-2032 (USD Million)
  • 6.5. Particle-Enhanced Nephelometric Immunoassay (PENIA)
    • 6.5.1. Global Cystatin C Assay Market, by Particle-Enhanced Nephelometric Immunoassay (PENIA), by Region, 2019-2032 (USD Million)
  • 6.6. Chemiluminescent Immunoassay (CLIA)
    • 6.6.1. Global Cystatin C Assay Market, by Chemiluminescent Immunoassay (CLIA), by Region, 2019-2032 (USD Million)
  • 6.7. Immunofluorescence Assay
    • 6.7.1. Global Cystatin C Assay Market, by Immunofluorescence Assay, by Region, 2019-2032 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Cystatin C Assay Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Cystatin C Assay Market, by Sample Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
  • 7.3. Blood
    • 7.3.1. Global Cystatin C Assay Market, by Blood, by Region, 2019-2032 (USD Million)
  • 7.4. Urine
    • 7.4.1. Global Cystatin C Assay Market, by Urine, by Region, 2019-2032 (USD Million)

8. Global Cystatin C Assay Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
  • 8.3. Diagnostics
    • 8.3.1. Global Cystatin C Assay Market, by Diagnostics, by Region, 2019-2032 (USD Million)
  • 8.4. Research
    • 8.4.1. Global Cystatin C Assay Market, by Research, by Region, 2019-2032 (USD Million)

9. Global Cystatin C Assay Market, by End-user

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
  • 9.3. Hospitals
    • 9.3.1. Global Cystatin C Assay Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 9.4. Clinical Laboratories
    • 9.4.1. Global Cystatin C Assay Market, by Clinical Laboratories, by Region, 2019-2032 (USD Million)
  • 9.5. Pharmaceutical and Biotechnology Companies
    • 9.5.1. Global Cystatin C Assay Market, by Pharmaceutical and Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 9.6. Others
    • 9.6.1. Global Cystatin C Assay Market, by Others, by Region, 2019-2032 (USD Million)

10. Global Cystatin C Assay Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Cystatin C Assay Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. Cystatin C Assay Market - North America
    • 10.3.1. North America: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
    • 10.3.2. North America: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
    • 10.3.3. North America: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
    • 10.3.4. North America: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
    • 10.3.5. North America: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.3.6. Cystatin C Assay Market - U.S.
      • 10.3.6.1. U.S.: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.3.7. Cystatin C Assay Market - Canada
      • 10.3.7.1. Canada: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
  • 10.4. Cystatin C Assay Market - Europe
    • 10.4.1. Europe: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
    • 10.4.2. Europe.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
    • 10.4.3. Europe: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
    • 10.4.4. Europe: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
    • 10.4.5. Europe: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.6. Cystatin C Assay Market - UK
      • 10.4.6.1. UK: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.6.3. UK: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.6.4. UK: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.6.5. UK: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.7. Cystatin C Assay Market - France
      • 10.4.7.1. France: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.7.2. France.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.7.3. France: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.7.4. France: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.7.5. France: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.8. Cystatin C Assay Market - Germany
      • 10.4.8.1. Germany: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.9. Cystatin C Assay Market - Italy
      • 10.4.9.1. Italy: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.10. Cystatin C Assay Market - Spain
      • 10.4.10.1. Spain: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.11. Cystatin C Assay Market - Netherlands
      • 10.4.11.1. Netherlands: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.4.12. Cystatin C Assay Market - Russia
      • 10.4.12.1. Russia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
  • 10.5. Cystatin C Assay Market - Asia Pacific
    • 10.5.1. Asia Pacific: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.5.6. Cystatin C Assay Market - China
      • 10.5.6.1. China: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.5.6.2. China.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.5.6.3. China: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.5.6.4. China: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.5.6.5. China: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.5.7. Cystatin C Assay Market - India
      • 10.5.7.1. India: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.5.7.2. India.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.5.7.3. India: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.5.7.4. India: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.5.7.5. India: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.5.8. Cystatin C Assay Market - Japan
      • 10.5.8.1. Japan: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.5.9. Cystatin C Assay Market - Malaysia
      • 10.5.9.1. Malaysia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.5.10. Cystatin C Assay Market - Indonesia
      • 10.5.10.1. Indonesia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.5.11. Cystatin C Assay Market - South Korea
      • 10.5.11.1. South Korea: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
  • 10.6. Cystatin C Assay Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.6.6. Cystatin C Assay Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.6.7. Cystatin C Assay Market - UAE
      • 10.6.7.1. UAE: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.6.8. Cystatin C Assay Market - Israel
      • 10.6.8.1. Israel: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.6.9. Cystatin C Assay Market - South Africa
      • 10.6.9.1. South Africa: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
  • 10.7. Cystatin C Assay Market - Latin America
    • 10.7.1. Latin America: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
    • 10.7.3. Latin America: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
    • 10.7.4. Latin America: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
    • 10.7.5. Latin America: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.7.6. Cystatin C Assay Market - Mexico
      • 10.7.6.1. Mexico: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.7.7. Cystatin C Assay Market - Brazil
      • 10.7.7.1. Brazil: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)
    • 10.7.8. Cystatin C Assay Market - Argentina
      • 10.7.8.1. Argentina: Cystatin C Assay Market, by Product, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: Cystatin C Assay Market, by Application, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: Cystatin C Assay Market, by Method, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: Cystatin C Assay Market, by Sample Type, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: Cystatin C Assay Market, by End-user, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Abbott (U.S.)
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Abcam plc (UK)
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Agilent Technologies, Inc (U.S.)
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Beckman Coulter, Inc. (U.S.)
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. bioMerieux, S.A (France)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Bio-Rad Laboratories, Inc (U.S.)
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Bio-Techne (U.S.)
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. DiaSys Diagnostic Systems GmbH (Germany)
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Randox Laboratories Ltd. (UK)
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Roche Diagnostics Limited (Switzerland)
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Siemens Healthcare Private Limited (India)
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Sino Biological, Inc. (China)
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Thermo Fisher Scientific Inc. (U.S.)
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제